The aim of our study was to investigate the significance of NF-κB levels as a serum marker in the monitoring of inflammation in breast and colon cancer; to show the relationship between NF-κB with inflammatory parameters. The gene discussed is NFKB1; the disease is malignant colon neoplasm.